Cleared Special

K192667 - gel-e Flex+ gel OTC (FDA 510(k) Clearance)

Oct 2019
Decision
30d
Days
-
Risk

K192667 is an FDA 510(k) clearance for the gel-e Flex+ gel OTC. This device is classified as a Hemostatic Wound Dressing Without Thrombin Or Other Biologics.

Submitted by Gel-E, Inc. (College Park, US). The FDA issued a Cleared decision on October 25, 2019, 30 days after receiving the submission on September 25, 2019.

This device falls under the General & Plastic Surgery FDA review panel. To Temporarily Control Bleeding And Cover External Wounds..

Submission Details

510(k) Number K192667 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 25, 2019
Decision Date October 25, 2019
Days to Decision 30 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QSY - Hemostatic Wound Dressing Without Thrombin Or Other Biologics
Device Class -
Definition To Temporarily Control Bleeding And Cover External Wounds.